Beiersdorf Aktiengesellschaft Q4 Earnings Call Highlights
View original at finance.yahoo.comBeiersdorf Aktiengesellschaft Q4 Earnings Call Highlights Beiersdorf Aktiengesellschaft logo Beiersdorf Aktiengesellschaft (ETR:BEI) management said the company delivered “stable” full-year 2025 results in a difficult operating backdrop, while outlining steps to restore momentum at its largest brand, NIVEA, and reaffir…
O que extraímos desta fonte
The claims Via News extracted from this document. We point to the source; we don't replace it.
Market dynamics had not improved at the start of 2026
80% confidenceLa Prairie's Q1 2026 performance would be down double digits
80% confidenceThe luxury market remains highly volatile with persistent weakness in the U.S. and travel retail
80% confidenceNIVEA Cellular Epigenetic Serum was the strongest NIVEA face care rollout in history
80% confidenceBeiersdorf would not reduce marketing investment proportionally despite margin pressure
80% confidenceEmployee safety was the top priority regarding Middle East volatility and it was too early to assess any potential business impact
80% confidenceConsumers became more cautious and increasingly selective in their routines
80% confidenceNIVEA's 2025 performance fell short of expectations due to market slowdown, China repositioning, and major innovations concentrated in second half
80% confidenceNIVEA Cellular Epigenetic Serum remains the number one serum across Europe
80% confidenceIndia, domestic China and Japan were cited as white spaces for Derma expansion
80% confidenceThe shift is primarily a reallocation of spending away from premium face care into body care, deodorants and affordable skincare, which are much less media intensive
80% confidenceBeiersdorf delivered stable full-year 2025 results in a difficult operating backdrop
80% confidenceEucerin Thiamidol Serum became the number one derma anti-pigment serum in China
80% confidenceBeiersdorf maintained its position as the best performing skincare company globally for the third year in a row
80% confidenceCash conversion was weaker than hoped and working capital rose above 10% of sales
80% confidenceThe global skincare market slowed materially, decelerating from mid-single-digit growth in 2024 to roughly 1.5% to 2% in 2025
80% confidence
